Company: CGCT
Filing Date: 2025-03-21
Form Type: S-1/A
Source: 0001104659-25-026623
Chunk: 191

Company: Cartesian Growth Corp III
Filing Date: 2025-03-21
Form: S-1/A
Chunk 191
---
                                                                        to us to cover offering related and organizational expenses. |
| CGC                                                                                                    
 III Sponsor DirectorCo LLC                                                                             |     | 100,000 Class B ordinary shares (of which 90,000 shares are held for the benefit of our independent                                 
 directors)                                                                                                                          |     |                                                                                                                  Approximately $435 |
| Holders                                                                                                
 of Class B ordinary shares                                                                             |     | Anti-dilution protection                                                                                                            
 upon conversion into Class A ordinary shares at a greater than one-to-one ratio                                                     |     |                                                                                                             Issuance of the Class A 
 ordinary shares issuable in connection with the conversion of the founder shares on a greater than one-to-one basis upon conversion |
| CGC                                                                                                    
 III Sponsor LLC, CGC III Sponsor DirectorCo LLC, our officers or directors, or our or their affiliates |     | Up to $1,500,000 in                                                                                                                 
 working capital loans, which loans may be convertible into warrants of the post-business combination entity at a price of $1.00 per 
 warrant at the option of the lender, which conversion may result in material dilution to our public shareholders                    |     |                                                                                                               Working capital loans 
                                                     to finance transaction costs in connection with an initial business combination |
|                                                                                                        |     | Reimbursement for any out-of-pocket                                                                                                 
 expenses related to identifying, investigating and completing an initial business combination                                       |     |                                                                                                              Services in connection 
                                                      with identifying, investigating and completing an initial business combination |
|                                                                                                        |     | Finder’s fees, advisory                                                                                                             
 fees, consulting fees or success fees                                                                                               |     |                                                                                                            Any services in order to 
 effectuate the completion of our initial business, which, if made prior to the completion of our initial business combination, will 
                                                                                   be paid from funds held outside the trust account |

Because our initial shareholders acquired
the founder shares at a nominal price, our public shareholders will incur immediate and substantial dilution upon the closing of this
offering, assuming no value is ascribed to the warrants included in the units. Further, the Class A ordinary shares issuable in
connection with the conversion of the founder shares may result in material dilution to our public shareholders due to the anti-dilution
rights of our founder shares that may result in an issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion.
If the private placement warrants become exercisable on a cashless basis, or if any working capital loans are converted into warrants
as described herein